Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOCETAXEL ANHYDROUS for Chemotherapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 86 adverse event reports in the FDA FAERS database where DOCETAXEL ANHYDROUS was used for Chemotherapy.

Most Reported Side Effects for DOCETAXEL ANHYDROUS

Side Effect Reports % Deaths Hosp.
Alopecia 1,047 96.6% 4 4
Hair texture abnormal 406 37.5% 2 4
Hair colour changes 404 37.3% 2 4
Hair disorder 393 36.3% 2 4
Madarosis 368 34.0% 2 5
Anxiety 107 9.9% 0 0
Emotional distress 83 7.7% 0 0
Depression 61 5.6% 0 0
Discomfort 38 3.5% 0 0
Deformity 34 3.1% 0 0
Pain 33 3.0% 0 0
Impaired quality of life 31 2.9% 0 0
Hair growth abnormal 22 2.0% 0 0
Mental fatigue 21 1.9% 0 0
Injury 13 1.2% 0 0

Other Indications for DOCETAXEL ANHYDROUS

Breast cancer female (134) Product used for unknown indication (134) Breast cancer (95) Breast cancer metastatic (18) Neoplasm malignant (15) Triple negative breast cancer (14) Invasive ductal breast carcinoma (12)

Other Drugs Used for Chemotherapy

CYCLOPHOSPHAMIDE (3,372) DOCETAXEL (2,134) CARBOPLATIN (1,902) DOXORUBICIN (1,756) VINCRISTINE (1,743) PACLITAXEL (1,425) OXALIPLATIN (1,423) METHOTREXATE (1,380) CYTARABINE (1,355) ETOPOSIDE (1,246)

Related Pages

DOCETAXEL ANHYDROUS Full Profile All Chemotherapy Drugs DOCETAXEL ANHYDROUS Demographics DOCETAXEL ANHYDROUS Timeline